Gland Pharma shares hit 52-week high; jump 7% despite market sell-off | Will rally continue after 93% YTD rise?
Gland Pharma is in focus with 9 November in focus.
· LiveMint Markets
The pharma stock opened in green at ₹3,147 apiece on NSE today, as compared to previous close of ₹3,132.80 on Sunday and touched an intraday high of ₹3,352 on 9 November.
Key facts
- Dates in focus
- 9 November
The analysis
Gland Pharma reported ₹3,147, ₹3,132.80 and ₹3,352, with movement of 7% and 93% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +5.9% on the day at ₹3,357.10, and has returned +20.4% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved +2.1% over the same period, so Gland Pharma is running 18.3 points ahead of its peers.
For Gland Pharma, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Why it matters
- With NSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- In focus: Gland Pharma (GLAND), in Pharma & Healthcare.
- Over three months: Gland Pharma +20.4% against Pharma & Healthcare +2.1% (18.3 points ahead).
- Trading well above normal today: Gland Pharma at 4.3 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Gland PharmaGLAND · Pharma & Healthcare | ₹3,357.10 | +5.9% | +1.7% | +20.4% | +5.9% | 4.3× | — |
Pharma & Healthcare
1M +7.5% · 3M +2.1%
Gland Pharma
Prices as of 9 Nov 2026, 10:39 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Gland Pharma Q2FY27 results: Net profit rises 58% to ₹290.75 crore
Divi's Labs Q2 result: Net profit rises 64% to ₹1,127 cr on higher revenue
Muhurat Trading LIVE: GIFT Nifty signals muted open; Tata Steel, Divi's Labs shares in focus
ICICI Bank, Divi's among 14 NSE 500 stocks hit new highs in Muhurat session
Muhurat Trading 2026: Tata Steel, Sun Pharma, BSE among top gainers as Nifty 50, Sensex swing between gains and losses